Contact Us

Macugen
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Macugen

Macugen Side Effects Could Result In Angiodema Lawsuits

Macugen | Lawsuits, Lawyers | Side Effects: Angiodema, Vision Loss, Swelling Around Eyes

Macugen (pegaptanib sodium), manufactured by Eyetech Pharmaceuticals Inc. and Pfizer, Inc., is prescribed to treat adults with an eye problem called the wet form (neovascular) of age-related macular degeneration. Macular degeneration results in vision loss that can lead to blindness. Macugen was granted FDA approval on December 17, 2004. It is administered every six weeks via injection into the eye. On April 7, 2006, Eyetech, Pfizer and the FDA notified ophthalmologic healthcare professionals, surgical service supervisors and other healthcare professionals of important changes in the approved product labeling for Macugen, including changes to the contraindications, precautions, adverse post-marketing events, and dosage and administrations sections on the label.

Macugen Side Effects & Reactions

There have been rare reports of anaphylaxis/anaphylactoid reactions including angioedema following the administration of Macugen along with various medications administered as part of the injection preparation. Angiodema is a reaction that causes swelling around the eyes, lips and often genitals, hands and feet. It is recommended that healthcare professionals evaluate the patient's medical history for hypersensitivity reactions to Macugen prior to prescribing the drug.

About Macular Degeneration

Age-related macular degeneration (AMD) is an eye condition that affects the retina, which is the back part of your eye. The center of the retina contains the macula. The macula allows you to see objects straight ahead, which is called central vision. Macular degeneration damages the macula, which causes you to lose your central vision. Wet AMD results from the growth of abnormal, leaky blood vessels below the retina. Age-related macular degeneration (AMD) occurs in people over 60. Today, at least 15 million people in the United States have this health problem.

Legal Help For Victims Affected By Macugen

If you or a loved one took Macugen and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).



 

MacugenRSS Feed

Macugen: rare cases of anaphylaxis/anaphylactoid reactions

Apr 16, 2006 | www.xagena.it
Rare cases of anaphylaxis/anaphylactoid reactions, including angioedema, have been reported in the post-marketing experience following the Macugen ( Pegaptanib sodium injection ) intravitreal administration procedure. Macugen is indicated for the treatment of neovascular ( wet ) age-related macular degeneration, and is administered once every six weeks by intravitreous injection. Since market introduction in the United States, there have been rare reports of anaphylaxis/ anaphylactoid...

Macugen (pegaptanib sodium injection) Labeling Change

Apr 7, 2006 | www.pharmalive.com
Pfizer Pharmaceuticals notified healthcare professionals of important changes in the approved product labeling for Macugen (pegaptanib sodium injection), including changes to the CONTRAINDICATIONS, PRECAUTIONS, ADVERSE EVENTS Post-Marketing, and DOSAGE and ADMINISTRATION sections. Rare reports of anaphylaxis/anaphylactoid reactions, including angioedema following the administration of Macugen along with various medications administered as part of the injection preparation, were...

More Macugen News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo